Bain Capital and Kohlberg have completed a strategic investment in PCI Pharma Services, according to a news release.
PCI, established in 1971 and trading as Packaging Coordinators Inc. (PCI), is a Philadelphia-based global contract development and manufacturing organization that provides drug development, manufacturing and packaging solutions.
Kohlberg, the existing lead investor in PCI, was founded in 1987 and is based in Mount Kisco, New York. It is a private equity firm that invests in healthcare services, pharmaceutical/medical products and services, and several other sectors. The firm pursues a range of investment types and seeks to invest in companies with an enterprise value of $500 million to $4 billion that generate $50 million to $250 million in EBITDA.
Bain Capital Private Equity, founded in 1984 and based in Boston, focuses on making control and minority equity investments and prefers to make more substantial investments from a dollars perspective. The firm invests in healthcare and several other industries. Within healthcare, Bain Capital Private Equity targets companies in the provider services, hospital/major facilities, life sciences/pharmaceutical and non-reimbursement industries.
Bain and Kohlberg were supported with significant reinvestment by Mubadala Investment Company and a minority investment from Partners Group, according to the release.
Terms of the investment were not disclosed.
